These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 14755031)

  • 41. Sero-epidemiological and -sociological patterns of herpes simplex virus infection in the world.
    Nahmias AJ; Lee FK; Beckman-Nahmias S
    Scand J Infect Dis Suppl; 1990; 69():19-36. PubMed ID: 2175939
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Genital herpes: epidemiology, transmission, clinic, asymptomatic viral excretion, impact on other sexually transmitted diseases, prevention, and treatment].
    Bossi P
    Ann Dermatol Venereol; 2002 Apr; 129(4 Pt 2):477-93. PubMed ID: 12122319
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Herpes simplex virus type 2: epidemiology and management options in developing countries.
    Paz-Bailey G; Ramaswamy M; Hawkes SJ; Geretti AM
    Sex Transm Infect; 2007 Feb; 83(1):16-22. PubMed ID: 17098770
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Comparison of different forms of herpes simplex replication-defective mutant viruses as vaccines in a mouse model of HSV-2 genital infection.
    Da Costa XJ; Morrison LA; Knipe DM
    Virology; 2001 Sep; 288(2):256-63. PubMed ID: 11601897
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Ocular herpes simplex: changing epidemiology, emerging disease patterns, and the potential of vaccine prevention and therapy.
    Pepose JS; Keadle TL; Morrison LA
    Am J Ophthalmol; 2006 Mar; 141(3):547-557. PubMed ID: 16490506
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Genital shedding of herpes simplex virus type 2 in childbearing-aged and pregnant women living in Gabon.
    Ozouaki F; Ndjoyi-Mbiguino A; Legoff J; Onas IN; Kendjo E; Si-Mohamed A; Mbopi-Kéou FX; Malkin JE; Bélec L
    Int J STD AIDS; 2006 Feb; 17(2):124-7. PubMed ID: 16464276
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Comparative efficacy and immunogenicity of replication-defective, recombinant glycoprotein, and DNA vaccines for herpes simplex virus 2 infections in mice and guinea pigs.
    Hoshino Y; Dalai SK; Wang K; Pesnicak L; Lau TY; Knipe DM; Cohen JI; Straus SE
    J Virol; 2005 Jan; 79(1):410-8. PubMed ID: 15596834
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Virologic characteristics of subclinical and symptomatic genital herpes infections.
    Wald A; Zeh J; Selke S; Ashley RL; Corey L
    N Engl J Med; 1995 Sep; 333(12):770-5. PubMed ID: 7643884
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Genital Herpes Simplex Virus Type 2 Shedding Among Adults With and Without HIV Infection in Uganda.
    Phipps W; Nakku-Joloba E; Krantz EM; Selke S; Huang ML; Kambugu F; Orem J; Casper C; Corey L; Wald A
    J Infect Dis; 2016 Feb; 213(3):439-47. PubMed ID: 26486633
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Herpes simplex virus type 1 as a cause of genital herpes: impact on surveillance and prevention.
    Lafferty WE; Downey L; Celum C; Wald A
    J Infect Dis; 2000 Apr; 181(4):1454-7. PubMed ID: 10762576
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Prophylactic Herpes Simplex Virus 2 (HSV-2) Vaccines Adjuvanted with Stable Emulsion and Toll-Like Receptor 9 Agonist Induce a Robust HSV-2-Specific Cell-Mediated Immune Response, Protect against Symptomatic Disease, and Reduce the Latent Viral Reservoir.
    Hensel MT; Marshall JD; Dorwart MR; Heeke DS; Rao E; Tummala P; Yu L; Cohen GH; Eisenberg RJ; Sloan DD
    J Virol; 2017 May; 91(9):. PubMed ID: 28228587
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Novel Role for Interleukin-17 in Enhancing Type 1 Helper T Cell Immunity in the Female Genital Tract following Mucosal Herpes Simplex Virus 2 Vaccination.
    Bagri P; Anipindi VC; Nguyen PV; Vitali D; Stämpfli MR; Kaushic C
    J Virol; 2017 Dec; 91(23):. PubMed ID: 28956763
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Herpes simplex virus infection in women in the WIHS: epidemiology and effect of antiretroviral therapy on clinical manifestations.
    Ameli N; Bacchetti P; Morrow RA; Hessol NA; Wilkin T; Young M; Cohen M; Minkoff H; Gange SJ; Greenblatt RM
    AIDS; 2006 Apr; 20(7):1051-8. PubMed ID: 16603858
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Does frequency of genital herpes recurrences predict risk of transmission? Further analysis of the valacyclovir transmission study.
    Kim HN; Wald A; Harris J; Almekinder J; Heitman C; Corey L
    Sex Transm Dis; 2008 Feb; 35(2):124-8. PubMed ID: 17921912
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Current Concepts for Genital Herpes Simplex Virus Infection: Diagnostics and Pathogenesis of Genital Tract Shedding.
    Johnston C; Corey L
    Clin Microbiol Rev; 2016 Jan; 29(1):149-61. PubMed ID: 26561565
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The population impact of herpes simplex virus type 2 (HSV-2) vaccination on the incidence of HSV-2, HIV and genital ulcer disease in South Africa: a mathematical modelling study.
    Stone J; Looker KJ; Silhol R; Turner KME; Hayes R; Coetzee J; Baral S; Schwartz S; Mayaud P; Gottlieb S; Boily MC; Vickerman P
    EBioMedicine; 2023 Apr; 90():104530. PubMed ID: 36933410
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Reactivation of genital herpes simplex virus type 2 infection in asymptomatic seropositive persons.
    Wald A; Zeh J; Selke S; Warren T; Ryncarz AJ; Ashley R; Krieger JN; Corey L
    N Engl J Med; 2000 Mar; 342(12):844-50. PubMed ID: 10727588
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Improving immunogenicity and efficacy of vaccines for genital herpes containing herpes simplex virus glycoprotein D.
    Awasthi S; Shaw C; Friedman H
    Expert Rev Vaccines; 2014 Dec; 13(12):1475-88. PubMed ID: 25138572
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Predicting the potential individual- and population-level effects of imperfect herpes simplex virus type 2 vaccines.
    Schwartz EJ; Blower S
    J Infect Dis; 2005 May; 191(10):1734-46. PubMed ID: 15838802
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Maternal herpes simplex virus type 2 coinfection increases the risk of perinatal HIV transmission: possibility to further decrease transmission?
    Bollen LJ; Whitehead SJ; Mock PA; Leelawiwat W; Asavapiriyanont S; Chalermchockchareonkit A; Vanprapar N; Chotpitayasunondh T; McNicholl JM; Tappero JW; Shaffer N; Chuachoowong R
    AIDS; 2008 Jun; 22(10):1169-76. PubMed ID: 18525263
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.